Headquartered in New York, NY Fiscal year ends December NYSE: CNS cohenandsteers.com
Cohen & Steers is a global investment manager specializing in real assets and alternative income strategies, including listed and private real estate, preferred securities, infrastructure, resource equities, commodities, and multi-strategy solutions. Founded in 1986, the firm manages approximately $95.9 billion in assets across open-end funds, ETFs, SICAVs, institutional accounts, and closed-end funds. The company serves wealth and institutional client channels globally, with offices in New York, London, Dublin, Hong Kong, Tokyo, and Singapore. Cohen & Steers has been expanding its platform through active ETF launches, private real estate fund acquisitions, and international distribution partnerships. Updated
CNS Pharmaceuticals (NASDAQ:CNSP) is back on every biotech watchlist after a 242.36% one-week ramp tied to its Berubicin glioblastoma story. But here’s what you should actually be watching. Holders captured the move;…
In the past week or so, renowned investors Carl Icahn and Mario Gabelli led some huge insider buying. These were not the only notable purchases though.
Cohen & Steers is a global investment manager specializing in real assets and alternative income strategies, including listed and private real estate, preferred securities, infrastructure, resource equities, commodities, and multi-strategy solutions.
24/7 Wall St.'s 12-month price target for CNS is $78.78, rated Buy. The Wall Street consensus target is $71.67. CNS price prediction →
